Literature DB >> 26260042

Haematological cancer: promising results of BCL2 inhibition.

Diana Romero.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26260042     DOI: 10.1038/nrclinonc.2015.139

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.

Authors:  Ute Fischer; Michael Forster; Anna Rinaldi; Thomas Risch; Stéphanie Sungalee; Hans-Jörg Warnatz; Beat Bornhauser; Michael Gombert; Christina Kratsch; Adrian M Stütz; Marc Sultan; Joelle Tchinda; Catherine L Worth; Vyacheslav Amstislavskiy; Nandini Badarinarayan; André Baruchel; Thies Bartram; Giuseppe Basso; Cengiz Canpolat; Gunnar Cario; Hélène Cavé; Dardane Dakaj; Mauro Delorenzi; Maria Pamela Dobay; Cornelia Eckert; Eva Ellinghaus; Sabrina Eugster; Viktoras Frismantas; Sebastian Ginzel; Oskar A Haas; Olaf Heidenreich; Georg Hemmrich-Stanisak; Kebria Hezaveh; Jessica I Höll; Sabine Hornhardt; Peter Husemann; Priyadarshini Kachroo; Christian P Kratz; Geertruy Te Kronnie; Blerim Marovca; Felix Niggli; Alice C McHardy; Anthony V Moorman; Renate Panzer-Grümayer; Britt S Petersen; Benjamin Raeder; Meryem Ralser; Philip Rosenstiel; Daniel Schäfer; Martin Schrappe; Stefan Schreiber; Moritz Schütte; Björn Stade; Ralf Thiele; Nicolas von der Weid; Ajay Vora; Marketa Zaliova; Langhui Zhang; Thomas Zichner; Martin Zimmermann; Hans Lehrach; Arndt Borkhardt; Jean-Pierre Bourquin; Andre Franke; Jan O Korbel; Martin Stanulla; Marie-Laure Yaspo
Journal:  Nat Genet       Date:  2015-07-27       Impact factor: 38.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.